DE SB76 | 2021-2022 | 151st General Assembly
Status
Completed Legislative Action
Spectrum: Moderate Partisan Bill (Democrat 17-3)
Status: Passed on June 3 2021 - 100% progression
Action: 2021-06-03 - Signed by Governor
Text: Latest bill text (Draft #1) [HTML]
Spectrum: Moderate Partisan Bill (Democrat 17-3)
Status: Passed on June 3 2021 - 100% progression
Action: 2021-06-03 - Signed by Governor
Text: Latest bill text (Draft #1) [HTML]
Summary
This Act authorizes the distribution of testing strips to determine the presence of fentanyl or fentanyl-related substances. Fentanyl testing strips could be distributed to the community along with opioid overdose reversal medication as a harm reduction strategy in the opioid addiction crisis. A number of states have authorized fentanyl testing strips distribution in recent years including Maryland, Rhode Island, the District of Columbia, and North Carolina. Twenty-seven states currently provide fentanyl testing strips through needle exchange programs.
Title
An Act To Amend Title 16 Of The Delaware Code Relating To Fentanyl Testing Strips.
Sponsors
Roll Calls
2021-04-22 - House - House Third Reading (Y: 40 N: 0 NV: 0 Abs: 1) [PASS]
2021-03-23 - Senate - Senate Third Reading (Y: 21 N: 0 NV: 0 Abs: 0) [PASS]
2021-03-23 - Senate - Senate Third Reading (Y: 21 N: 0 NV: 0 Abs: 0) [PASS]
History
Date | Chamber | Action |
---|---|---|
2021-06-03 | Signed by Governor | |
2021-04-22 | Passed By House. Votes: 40 YES 1 ABSENT | |
2021-04-16 | Suspension of Rules in House | |
2021-03-31 | Reported Out of Committee (Health & Human Development) in House with 8 Favorable, 6 On Its Merits | |
2021-03-24 | Assigned to Health & Human Development Committee in House | |
2021-03-23 | Passed By Senate. Votes: 21 YES | |
2021-03-17 | Reported Out of Committee (Health & Social Services) in Senate with 5 Favorable | |
2021-03-04 | Introduced and Assigned to Health & Social Services Committee in Senate |